Non-resectable congenital tumors with the ETV6-NTRK3 gene fusion are highly responsive to chemotherapy

Medical and Pediatric Oncology

Volumn 40, Issue 5, 2003, Pages 288-292

  McCahon, Emma ^b   Sorensen, Poul H B ^a   Davis, Jeff H ^a   Rogers, Paul C J ^a   Schultz, Kirk R ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

Author keywords

Chemotherapy; ETV6 NTRK3; Fibrosarcoma; Mesoblastic nephroma

Indexed keywords

ANTHRACYCLINE; CYCLOPHOSPHAMIDE; DACTINOMYCIN; DOXORUBICIN; IFOSFAMIDE; VINCRISTINE;

AMPUTATION; ARTICLE; BIRTH; CANCER CHEMOTHERAPY; CANCER SURGERY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CONGENITAL TUMOR; FEMALE; FEVER; FIBROSARCOMA; GENE FUSION; HAMSTRING; HUMAN; HUMAN TISSUE; INFANT; LIVER TOXICITY; MALE; MESOBLASTIC NEPHROMA; NEUTROPENIA; NUCLEAR MAGNETIC RESONANCE IMAGING; PREOPERATIVE CARE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIDE EFFECT; THIGH; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA; TREATMENT OUTCOME; TUMOR BIOPSY;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DNA-BINDING PROTEINS; FEMALE; FIBROSARCOMA; GENETIC MARKERS; HUMANS; INFANT, NEWBORN; KIDNEY NEOPLASMS; MALE; NEPHROMA, MESOBLASTIC; PROTO-ONCOGENE PROTEINS C-ETS; RECEPTOR, TRKC; REPRESSOR PROTEINS; SOFT TISSUE NEOPLASMS; TRANSLOCATION, GENETIC;

EID: 0037402106     PISSN: 00981532     EISSN: None     Source Type: Journal    
DOI: 10.1002/mpo.10272     Document Type: Article

References (23)

1. Knezevich SR, McFadden DE, Tao W, et al. A novel ETV6-NTRK3 gene fusion in congenital fibrosarcoma. Nat Genet 1998; 18:184-187.
2. Rubin BP, Chen CJ, Morgan TW, et al. Congenital mesoblastic nephroma t(12;15) is associated with ETV6-NTRK3 gene fusion: Cytogenetic and molecular relationship to congenital (infantile) fibrosarcoma. Am J Pathol 1998;153:1451-1458.
3. Knezevich SR, Garnett MJ, Pysher TJ, et al. ETV6-NTRK3 gene fusions and trisomy 11 establish a histogenic link between mesoblastic nephroma and congenital fibrosarcoma. Cancer Res 1998; 58:5046-5048.
4. Stalens J-P, Gosseye S, Clapuyt P, et al. Preoperative chemotherapy of congenital mesoblastic nephroma in a 5-month-old infant. Pediatr Hematol Oncol 1992;9:335-345.
5. Kurkchubasche AG, Halvorson EG, Forman EN, et al. The role of preoperative chemotherapy in the treatment of infantile fibrosarcoma. J Pediatr Surg 2000;35(6):880-883.
6. Bourgeois JM, Knezevich SR, Mathers JA, et al. Molecular detection of the ETV6-NTRK3 gene fusion differentiates congenital fibrosarcoma from other childhood spindle cell tumors. Am J Surg Pathol 2000;24:937-467.
7. Miser JS, Triche TJ, Kinsella TJ, et al. Other soft tissue sarcomas of childhood. In: Pizzo PA, Poplack DG, editors. Principles and practice of pediatric oncology. Lippincott-Raven Philadelphia, PA; 1997. pp. 873-875.
8. Parham DM, editors. Pediatric neoplasia: Morphology and biology. Philadelphia: Lippincott-Raven; 1996. 47p-49p.
9. Bisceglia M, Carosi I, Vairo M, et al. Congenital mesoblastic nephroma: Report of a case with review of the most significant literature. Pathol Res Pract 2000;196:199-204.
10. Wai DH, Knezevich SR, Lucas T, et al. The ETV6-NTRK3 gene fusion encodes a chimeric protein kinase that transforms NIH3T3 cells. Oncogene 2000;19:906-915.
11. Tognon C, Garnett M, Kenward E, et al. The chimeric protein tyrosine kinase ETV6-NTRK3 requires both Ras-Erk1/2 and PI3-kinase-Akt signaling for fibroblast transformation. Cancer Res 2001;61:8909-8916.
12. Beckwith JB, Weeks DA. Congenital mesoblastic nephroma: When should we worry? Arch Pathol Lab Med 1986;110:98-99.
13. Argani P, Faria PA, Epstein JI, et al. Primary renal synovial sarcoma: Molecular and morphologic delineation of an entity previously included among embryonal sarcomas of the kidney. Am J Surg Pathol 2000;24:1087-1096.
14. Gormley TS, Skoog SJ, Jones RV, et al. Cellular congenital mesoblastic nephroma: What are the options? J Urol 1989;142: 479-483.
15. Soule EH, Pritchard DJ. Fibrosarcoma in infants and children. A review of 110 cases. Cancer 1977;40:1711-1721.
16. Chan KL, Chan KW, Lee CW, et al. Preoperative chemotherapy for mesoblastic nephroma. Med Pediatr Oncol 1995;24:271-273.
17. Kynaston JA, Malcolm AJ, Craft AW, et al. Chemotherapy in the management of infantile fibrosarcoma. Med Pediatr Oncol 1993;21:488-493.
18. Grier HE, Perez-Atayde AR, Weinstein HJ. Chemotherapy for inoperable infantile fibrosarcoma. Cancer 1985;56:1507-1510.
19. Brock P, Renard M, Smet M, et al. Letter to the Editor: Infantile fibrosarcoma. Med Pediatr Oncol 1991;19:210.
20. Ninane J, Gosseye S, Panteon E, et al. Congenital fibrosarcoma: Preoperative chemotherapy and conservative surgery. Cancer 1986;58:1400-1406.
21. Shetty AK, Yu LC, Gardner RV, et al. Brief Report: Role of chemotherapy in treatment of infantile fibrosarcoma. Med Pediatr Oncol 1999;33:425-427.
22. Hamm CM, Pyesmany A, Resch L. Case Report: Congenital retroperitoneal fibrosarcoma. Med Pediatr Oncol 1997;28:65-68.
23. Siegal SE, Morgan RD. Problems in the chemotherapy of cancer in the neonate. Am J Pediatr Hematol Oncol 1981;3:287.